QuickView for CD20;jsessionid=822365FAA897C9CB9A11B86E1FB23AB2;jsessionid=844F0AC56AA6597FD7A9BBDA03C97E2A;jsessionid=0F7C707A8230094427981162954378E7 (gene)

Summary
General Info

Body Atlas

Most Correlated Tissues

Tonsil
B lymphocyte (naive) of spleen
Spleen
B lymphocyte (IgM memory) of spleen
Lymph nodes

Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

Disorder of lung
Common variable immunodeficiency
Infection due to Mycobacterium abscessus
Sjögren's syndrome
Infection due to Citrobacter

Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

iodine-131 anti-B1 antibody
rituximab
Platelet Factor 4
naphthalene
X-Rays

Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

NCSTN
BECN1
TNFRSF9
IL10RB
CD247

Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Explore Curated Studies Results

Literature

Most Relevant Literature

Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability.
Cross-Reactivity of Antibodies to Rituximab with Other Therapeutic Anti-CD20 Antibodies.
Switching from natalizumab to an anti-CD20 monoclonal antibody in relapsing remitting multiple scler…
Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell …
CD20/MS4A1 is a mammalian olfactory receptor expressed in a subset of olfactory sensory neurons that…

Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for CD20;jsessionid=822365FAA897C9CB9A11B86E1FB23AB2;jsessionid=844F0AC56AA6597FD7A9BBDA03C97E2A;jsessionid=0F7C707A8230094427981162954378E7

Explore Clinical Trials Results